We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Innova Biosciences Awarded EU Grant to Develop Cancer Biomarker Discovery Platform
News

Innova Biosciences Awarded EU Grant to Develop Cancer Biomarker Discovery Platform

Innova Biosciences Awarded EU Grant to Develop Cancer Biomarker Discovery Platform
News

Innova Biosciences Awarded EU Grant to Develop Cancer Biomarker Discovery Platform

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Innova Biosciences Awarded EU Grant to Develop Cancer Biomarker Discovery Platform"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Innova Biosciences Ltd has been awarded €455,000 of a €3,000,000 European grant. Through the PROACTIVE consortium along with Olink, Copenhagen University, Fujirebio Diagnostics AB, Uppsala University, and Integromics S.L., a high throughput plasma screening platform will be developed for the discovery of biomarkers of early stage cancer.

Innova Biosciences has had enormous success with its range of Lightning-Link™ bioconjugation products, which provide a simple method for joining biomolecules, a process carried out in thousands of research laboratories worldwide.

Innova Biosciences’ participation in the PROACTIVE consortium to develop immunodiagnostics reagents will help cement the company’s position as a world leader in bioconjugation technology.

Commenting on the EU grant Dr Nick Gee, CEO of Innova Biosciences said “We are delighted to be granted such a prestigious award which recognizes Innova’s proprietary knowledge and expertise. Participating in the development of a new immunodiagnostic platform that will facilitate early stage cancer detection is an exciting application of our technology, which will directly benefit human health.”
Advertisement